Whereas MEN 2A and 2B are clinically very well defined, the lack of specific clinical features and/or familial history makes the diagnosis of FMTC relatively difficult, thus generating an underestimation of FMTC prevalence within families, especially in series where no genetic test for RET mutation has been performed. Here, RET is linked to multiple endocrine neoplasia type 2A.